Martin Vanderlaan | BioProcess International

BioProcess International is part of the Informa Connect Division of Informa PLC

Informa PLC|ABOUT US|INVESTOR RELATIONS|TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BPI Events About Subscribe Contribute

Upstream

Recent in Upstream

See all

Croda Pharma Ask the Expert

Sponsored Content

Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency

byBPI Contributor

Oct 29, 2024

1 Hr View

Sartorius

Sponsored Content

Building Reliability Into Scale-Up: Targeted Optimization for AAV Production Building Reliability Into Scale-Up: Targeted Optimization for AAV Production

byBPI Contributor

Sep 17, 2024

40 Min View

Downstream

Recent in Downstream

See all

Bio-Rad Ask the Expert webcast

Sponsored Content

Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges

byBPI Contributor

Nov 14, 2024

15 Min View

Cygnus AAE-MS

Sponsored Content

AAE-MS™: A Powerful Method to Assess Host Cell Protein ELISA Fit for Purpose AAE-MS™: A Powerful Method to Assess Host Cell Protein ELISA Fit for Purpose

byBPI Contributor

Nov 13, 2024

35 Min View

Manufacturing

Recent in Manufacturing

See all

Lonza Ask the Expert

Sponsored Content

Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System

byBPI Contributor

Oct 31, 2024

50 Min View

Single Use Support Ask the Expert webcast

Sponsored Content

What if Your Supply Chain for Single-Use Equipment Was Robust?What if Your Supply Chain for Single-Use Equipment Was Robust?

byBPI Contributor

Oct 24, 2024

30 Min View

Analytical

Recent in Analytical

See all

ValGenesis Ask the Expert webinar

Sponsored Content

Out of the Box Computer Software Assurance with ValGenesis VLMS Out of the Box Computer Software Assurance with ValGenesis VLMS

byBPI Contributor

Nov 7, 2024

30 Min View

Samsung S-Tesify

Sponsored Content

Innovative Approaches to Enhance Cell Culture Density for High-Quality Production Innovative Approaches to Enhance Cell Culture Density for High-Quality Production

byBPI Contributor

Sep 19, 2024

15 Min View

Business

Recent in Business

See all

thumbnail

Bioprocess Insider

Key strategies for effective technology evaluation Key strategies for effective technology evaluation

byKim Bennett

Aug 8, 2024

2 Min Read

Resilience logo

Sponsored Content

Built to Serve Innovation: A Briefing on Commercial Readiness at Resilience Built to Serve Innovation: A Briefing on Commercial Readiness at Resilience

byBPI Contributor

Jun 25, 2024

15 Min View

Therapeutic Modalities

Recent in Therapeutic Modalities

See all

Roche ATE webinar

Sponsored Content

Decoding AAV Manufacturing: Navigating Critical Quality Attributes and their Analytics Decoding AAV Manufacturing: Navigating Critical Quality Attributes and their Analytics

byBPI Contributor

Oct 11, 2024

20 Min View

thumbnail

Bioprocess Insider

Biomanufacturing in space accelerating therapy development on Earth Biomanufacturing in space accelerating therapy development on Earth

byJosh Abbott

Jul 24, 2024

3 Min Read

BioProcess Insider

Recent in BioProcess Insider

See all

thumbnail

Therapeutic Class

Post-pandemic dip: Panelists discuss CGT challenges Post-pandemic dip: Panelists discuss CGT challenges

byShreeyashi Ojha

Nov 8, 2024

3 Min Read

LumaCyte Laser Force Technology

Sponsored Content

Quantitative Cell Characterization Using Laser Force Cytology™ (LFC): The Future of Precision Manufacturing Quantitative Cell Characterization Using Laser Force Cytology™ (LFC): The Future of Precision Manufacturing

byBPI Contributor

Nov 5, 2024

3 Min Read

Home
Martin Vanderlaan

Martin Vanderlaan

Latest from Martin Vanderlaan

Hamster Phospholipase B-Like 2 (PLBL2): A Host-Cell Protein Impurity in Therapeutic Monoclonal Antibodies Derived from Chinese Hamster Ovary Cells

Bioanalytical Methods

Hamster Phospholipase B-Like 2 (PLBL2): A Host-Cell Protein Impurity in Therapeutic Monoclonal Antibodies Derived from Chinese Hamster Ovary Cells Hamster Phospholipase B-Like 2 (PLBL2): A Host-Cell Protein Impurity in Therapeutic Monoclonal Antibodies Derived from Chinese Hamster Ovary Cells

byMartin Vanderlaan, Wendy Sandovaland 21 more

Apr 14, 2015

Webinars

Ask the Expert webcasts

ATE Webcasts

Ask the Expert webcasts

ATE Webcasts

Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality

Ask the Expert webcasts

ATE Webcasts

Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality

BPI Podcasts

Voices of Biotech

Podcast: Sustainability is about health equity, says ScaleReady and Germfree

ScaleReady and Germfree discuss the need to rethink sustainability and move towards a more standardized and simplistic manufacturing model to ensure health equity can be achieved.

Insider News

CDMO success stories: News from Lonza, Samsung Bio, Fujifilm
Nov 21, 2024
|
3 Min Read
CSL dedicated to Hemgenix as it turns back on lenti-based gene therapies
Nov 20, 2024
|
2 Min Read
Bavarian Nordic talks mpox manufacturing expansion
Nov 19, 2024
|
3 Min Read
NIIMBL unveils antibody manufacturing action plan
Nov 19, 2024
|
2 Min Read

See all

CGT Europe

Dec 2 - Dec 5, 2024

The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success

Learn More